# Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia

> **NCT00759460** · PHASE3 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 250 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Sertindole
- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT00759460
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-03
- **Final completion:** 2008-04
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00759460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00759460, "Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00759460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*